Volume 131 Number 6, Jun 2016

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
    Author(s): David N. Louis; Arie Perry; Guido Reifenberger; Andreas Deimling; Dominique Figarella-Branger; Webster K. Cavenee; Hiroko Ohgaki; Otmar D. Wiestler; Paul Kleihues; David W. Ellison
    Pages: 803 - 820
  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
    Author(s): Vijay Ramaswamy; Marc Remke; Eric Bouffet; Simon Bailey; Steven C. Clifford; Francois Doz; Marcel Kool; Christelle Dufour; Gilles Vassal; Till Milde; Olaf Witt; Katja Hoff; Torsten Pietsch; Paul A. Northcott; Amar Gajjar; Giles W. Robinson; Laetitia Padovani; Nicolas André; Maura Massimino; Barry Pizer; Roger Packer; Stefan Rutkowski; Stefan M. Pfister; Michael D. Taylor; Scott L. Pomeroy
    Pages: 821 - 831
  • Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
    Author(s): Ibrahim Qaddoumi; Wilda Orisme; Ji Wen; Teresa Santiago; Kirti Gupta; James D. Dalton; Bo Tang; Kelly Haupfear; Chandanamali Punchihewa; John Easton; Heather Mulder; Kristy Boggs; Ying Shao; Michael Rusch; Jared Becksfort; Pankaj Gupta; Shuoguo Wang; Ryan P. Lee; Daniel Brat; V. Peter Collins; Sonika Dahiya; David George; William Konomos; Kathreena M. Kurian; Kathryn McFadden; Luciano Neder Serafini; Hilary Nickols; Arie Perry; Sheila Shurtleff; Amar Gajjar; Fredrick A. Boop; Paul D. Klimo; Elaine R. Mardis; Richard K. Wilson; Suzanne J. Baker; Jinghui Zhang; Gang Wu; James R. Downing; Ruth G. Tatevossian; David W. Ellison
    Pages: 833 - 845
  • Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
    Author(s): Barbara Rivera; Tenzin Gayden; Jian Carrot-Zhang; Javad Nadaf; Talia Boshari; Damien Faury; Michele Zeinieh; Romeo Blanc; David L. Burk; Somayyeh Fahiminiya; Eric Bareke; Ulrich Schüller; Camelia M. Monoranu; Ronald Sträter; Kornelius Kerl; Thomas Niederstadt; Gerhard Kurlemann; Benjamin Ellezam; Zuzanna Michalak; Maria Thom; Paul J. Lockhart; Richard J. Leventer; Milou Ohm; Duncan MacGregor; David Jones; Jason Karamchandani; Celia M. T. Greenwood; Albert M. Berghuis; Susanne Bens; Reiner Siebert; Magdalena Zakrzewska; Pawel P. Liberski; Krzysztof Zakrzewski; Sanjay M. Sisodiya; Werner Paulus; Steffen Albrecht; Martin Hasselblatt; Nada Jabado; William D. Foulkes; Jacek Majewski
    Pages: 847 - 863
  • Genomic characterization of primary central nervous system lymphoma
    Author(s): Kazutaka Fukumura; Masahito Kawazu; Shinya Kojima; Toshihide Ueno; Eirin Sai; Manabu Soda; Hiroki Ueda; Takahiko Yasuda; Hiroyuki Yamaguchi; Jeunghun Lee; Yukiko Shishido-Hara; Atsushi Sasaki; Mitsuaki Shirahata; Kazuhiko Mishima; Koichi Ichimura; Akitake Mukasa; Yoshitaka Narita; Nobuhito Saito; Hiroyuki Aburatani; Ryo Nishikawa; Motoo Nagane; Hiroyuki Mano
    Pages: 865 - 875
  • Methylation-based classification of benign and malignant peripheral nerve sheath tumors
    Author(s): Manuel Röhrich; Christian Koelsche; Daniel Schrimpf; David Capper; Felix Sahm; Annekathrin Kratz; Jana Reuss; Volker Hovestadt; David T. W. Jones; Melanie Bewerunge-Hudler; Albert Becker; Joachim Weis; Christian Mawrin; Michel Mittelbronn; Arie Perry; Victor-Felix Mautner; Gunhild Mechtersheimer; Christian Hartmann; Ali Fuat Okuducu; Mirko Arp; Marcel Seiz-Rosenhagen; Daniel Hänggi; Stefanie Heim; Werner Paulus; Jens Schittenhelm; Rezvan Ahmadi; Christel Herold-Mende; Andreas Unterberg; Stefan M. Pfister; Andreas Deimling; David E. Reuss
    Pages: 877 - 887
  • Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy
    Author(s): Koichi Ichimura; Shintaro Fukushima; Yasushi Totoki; Yuko Matsushita; Ayaka Otsuka; Arata Tomiyama; Tohru Niwa; Hirokazu Takami; Taishi Nakamura; Tomonari Suzuki; Kohei Fukuoka; Takaaki Yanagisawa; Kazuhiko Mishima; Yoichi Nakazato; Fumie Hosoda; Yoshitaka Narita; Soichiro Shibui; Akihiko Yoshida; Akitake Mukasa; Nobuhito Saito; Toshihiro Kumabe; Masayuki Kanamori; Teiji Tominaga; Keiichi Kobayashi; Saki Shimizu; Motoo Nagane; Toshihiko Iuchi; Masahiro Mizoguchi; Koji Yoshimoto; Kaoru Tamura; Taketoshi Maehara; Kazuhiko Sugiyama; Mitsutoshi Nakada; Keiichi Sakai; Yonehiro Kanemura; Masahiro Nonaka; Akio Asai; Kiyotaka Yokogami; Hideo Takeshima; Nobutaka Kawahara; Tatsuya Takayama; Masahiro Yao; Mamoru Kato; Hiromi Nakamura; Natsuko Hama; Ryuichi Sakai; Toshikazu Ushijima; Masao Matsutani; Tatsuhiro Shibata; Ryo Nishikawa
    Pages: 889 - 901
  • Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
    Author(s): Felix Sahm; Daniel Schrimpf; David T. W. Jones; Jochen Meyer; Annekathrin Kratz; David Reuss; David Capper; Christian Koelsche; Andrey Korshunov; Benedikt Wiestler; Ivo Buchhalter; Till Milde; Florian Selt; Dominik Sturm; Marcel Kool; Manuela Hummel; Melanie Bewerunge-Hudler; Christian Mawrin; Ulrich Schüller; Christine Jungk; Antje Wick; Olaf Witt; Michael Platten; Christel Herold-Mende; Andreas Unterberg; Stefan M. Pfister; Wolfgang Wick; Andreas Deimling
    Pages: 903 - 910
  • Dura mater is a potential source of Aβ seeds
    Author(s): Gabor G. Kovacs; Mirjam I. Lutz; Gerda Ricken; Thomas Ströbel; Romana Höftberger; Matthias Preusser; Günther Regelsberger; Selma Hönigschnabl; Angelika Reiner; Peter Fischer; Herbert Budka; Johannes A. Hainfellner
    Pages: 911 - 923
  • Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
    Author(s): Laura Piccio; Yuetiva Deming; Jorge L. Del-Águila; Laura Ghezzi; David M. Holtzman; Anne M. Fagan; Chiara Fenoglio; Daniela Galimberti; Barbara Borroni; Carlos Cruchaga
    Pages: 925 - 933
  • CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Author(s): Ju-Hee Kang; Brit Mollenhauer; Christopher S. Coffey; Jon B. Toledo; Daniel Weintraub; Douglas R. Galasko; David J. Irwin; Vivianna Van Deerlin; Alice S. Chen-Plotkin; Chelsea Caspell-Garcia; Teresa Waligórska; Peggy Taylor; Nirali Shah; Sarah Pan; Pawel Zero; Mark Frasier; Kenneth Marek; Karl Kieburtz; Danna Jennings; Caroline M. Tanner; Tanya Simuni; Andrew Singleton; Arthur W. Toga; Sohini Chowdhury; John Q. Trojanowski; Leslie M. Shaw
    Pages: 935 - 949

Impact Factor of Acta Neuropathologica

We are delighted to announce that the Impact Factor of Acta Neuropathologica has increased to 10.762 (2014)!

Ad